Latest Data & Signals Issued
|Signal Type||Signal Value||Data|
|Score||0.000||14 days ( 0 % )|
|Last Price||$0.775||0 %|
|High/ Low||$0.775 - $0.775||0%|
|Chg 7 Days||N/A||$0.775 $0.775|
|Chg 30 Days||-4.58 %||$0.81 $0.775|
|Chg 12 mos||244.29 %||$0.225 $0.775|
|Trend - 3 mos||-40.49 %||Width: 2546.11 %|
|Trend - 12 mos||65.21 %||Width: 986.04 %|
|Pred. range - 3 mos||N/A - $1.64||-100.00 % - 111.32 %|
|Pred. range - 12 mos||$0.649 - $7.05||-16.24 % - 809.72 %|
|Short mv avg 3 mos||Buy||2023-09-13 - 12 days|
|Long mv avg 3 mos||Buy||2023-07-31 - 43 days|
|Short/Long mv avg 3 mos||Sell||2023-07-18 - 52 days|
|Short mv avg 12 mos||Buy||2023-07-31 - 43 days|
|Long mv avg 12 mos||Sell||2023-08-10 - 35 days|
|Short/Long mv avg 12 mos||Sell||2023-08-24 - 25 days|
|Pivot Short||Buy||2023-09-06 - 17 days|
|Bollinger||Sell||0000-00-00 - N/A days|
|MACD||Buy||No Dates Stored For This Signal|
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Moving Average (7d)
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the ... ADMP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.